FDA-Approved Prostate Cancer Treatments
Approved prostate cancer drug treatments including formulations and usual dosing.
Oncology
FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
FDA-Approved Breast Cancer Treatments
FDA-approved oral and injectable treatment options for breast cancer.
No Added Benefit With Pembrolizumab Combo vs Monotherapy for Metastic NSCLC
Results showed the median OS was 21.4 months in the pembrolizumab plus ipilimumab arm compared with 21.9 months in the pembrolizumab monotherapy arm.
FDA-Approved Ovarian Cancer Treatments
FDA-Approved treatment options for individuals with ovarian cancer including dosing.
Antiemetic Treatments
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
Chemotherapy-Induced Nausea and Vomiting Guidelines: Prophylaxis
The ASCO guideline provides updated recommendations for the prevention and management of chemotherapy-induced nausea and vomiting (CINV) based on the emetic risk of the treatment regimen.
Effects of Drugs Targeting Mitochondrial Respiration in Melanoma
Despite relying on glycolysis, there is growing evidence that many tumor types still have high levels of mitochondrial energy metabolism and functioning oxidative phosphorylation. One such subset of tumors is melanoma, potentially playing a role in both tumor progression and resistance to therapy. This has led researchers to wonder whether targeting mitochondrial respiration could be…
-
Loading...
-
Loading...
Next post in Skin Cancer
